<!DOCTYPE html>
<html lang="en">
    <head>
        <title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
            table { border: 1px solid #dddddd; text-align: left; padding: 8px }
            td, th { border: 1px solid #dddddd; text-align: left; padding: 8px }
            tr:nth-child(even) { background-color: #dddddd }
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h2>Example Layout Pages</h2><hr><table><tr><th>DOI</th><th>Title</th></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539136.html>10.17917/ZB8P-FB40 </a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539138.html>10.17917/1VHC-MJ13 </a></td><td>NCL Method PCC-16: Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539139.html>10.17917/JM45-VA25</a></td><td>NCL Method PCC-18: Quantitation of APIs in Polymeric Prodrug Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539140.html>10.17917/8S1D-BN17 </a></td><td>NCL Method PCC-19: Asymmetric-Flow Field-Flow Fractionation</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539141.html>10.17917/WF0H-1V72 </a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539142.html>10.17917/V9AP-D094 </a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539143.html>10.17917/0165-RC67 </a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539144.html>10.17917/7GEJ-8G77</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539145.html>10.17917/YTHD-KF51</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539146.html>10.17917/822G-S949 </a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539147.html>10.17917/HA0Q-5B49</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539148.html>10.17917/EQCT-3C51</a></td><td>NCL Method ITA-5.2: Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539149.html>10.17917/C8XW-BQ05</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834048.html>10.17917/B68Q-T959</a></td><td>Supplement to NIST-NCL Joint Assay Protocols PCC-8 & PCC-9: Metal Quantitation by Inductively Coupled Plasma-Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834054.html>10.17917/WBSK-2W04 </a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834056.html>10.17917/GS4C-N171</a></td><td>NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834057.html>10.17917/M173-MY22  </a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834059.html>10.17917/QENR-XG24</a></td><td>NCL Method ITA-8.2: Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834060.html>10.17917/CPWX-SP39</a></td><td>NCL Method ITA-8.1: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834061.html>10.17917/ZTXV-XC08</a></td><td>NCL Method ITA-9.1: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834062.html>10.17917/WZGC-DG48</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834063.html>10.17917/GBQR-BN14</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834064.html>10.17917/416C-5429 </a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834065.html>10.17917/7SF3-7A88</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834066.html>10.17917/ZQ6R-KD69 </a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834067.html>10.17917/GMXG-BH29</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834068.html>10.17917/RD78-BZ75</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834069.html>10.17917/JQM0-0G48</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834070.html>10.17917/SJT2-7P72</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834071.html>10.17917/DM9W-8430 </a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/100335618.html>10.17917/P2T3-8P84</a></td><td>NCL Method ITA-27: Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/110788608.html>10.17917/30CJ-2J27 </a></td><td>NCL Method STE-2.2: Detection of Bacterial Contamination Using Luria Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/112853000.html>10.17917/DVJF-SS25 </a></td><td>NCL Method STE-2.1: Detection of Microbial Contamination Using Millipore Sampler Devices</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130946.html>10.17917/WFT5-1J52 </a></td><td>NCL Method STE-2.3: Detection of Bacterial Contamination Using Tryptic Soy Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130947.html>10.17917/86Y9-3Y16 </a></td><td>NCL Method STE-2.4: Detection of Bacterial Contamination using Tryptic Soy Agar Plates and RPMI Suspension Tests for the Purposes of Determining Bacterial ID</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130949.html>10.17917/G780-R621</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130950.html>10.17917/SCP8-6P58</a></td><td>NCL Method PCC-21: Measuring Size and Number Concentration of Metallic Nanoparticles using SP-ICP-MS</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130951.html>10.17917/QFEP-HD46</a></td><td>NCL Method PCC-22: Residual Organic Solvent Analysis in Nanoformulations Using Headspace Gas Chromatography</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130952.html>10.17917/7Z55-SJ80</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130954.html>10.17917/B5N6-F154</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Liposomal Products</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130955.html>10.17917/2MYC-DE76</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Colloidal Metal Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130956.html>10.17917/G13J-XR95</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Polymeric Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130957.html>10.17917/W63A-GR02 </a></td><td>Guide to NCL In Vivo Studies: Efficacy, Pharmacokinetics and Toxicology</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130958.html>10.17917/PBZB-N042 </a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130959.html> 10.17917/EYQD-3T61 </a></td><td>NCL Method ITA-29: Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130960.html>10.17917/C7K01C</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130961.html>10.17917/C7KW2Q </a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130962.html>10.17917/0J6M-EJ19 </a></td><td>NCL Method ITA-40: Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130963.html>10.17917/BA6D-TE29</a></td><td>NCL Method STE-4: Detection of Œ?-glucan contamination</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130988.html>10.17917/PHFP-8573 </a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130989.html>10.17917/B6HB-C950 </a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130990.html>10.17917/VRHF-5Y74 </a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130991.html>10.17917/RK6R-P820 </a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130992.html>10.17917/5WSQ-7X78</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130993.html>10.17917/3F5S-6728</a></td><td>NIST-NCL Joint Assay Protocol, PCC-1: Measuring the Size of Nanoparticles in Aqueous Media Using Batch-Mode Dynamic Light Scattering</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130994.html>10.17917/DHAG-PC35</a></td><td>NIST-NCL Joint Assay Protocol, PCC-6: Size Measurement of Nanoparticles Using Atomic Force Microscopy</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130995.html>10.17917/C7N7-N938</a></td><td>NIST-NCL Joint Assay Protocol, PCC-7: Measuring the Size of Nanoparticles Using Transmission Electron Microscopy (TEM)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130996.html>10.17917/SA6R-9D63</a></td><td>NIST-NCL Joint Assay Protocol, PCC-8: Determination of Gold in Rat Tissue with Inductively Coupled Plasma Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130997.html>10.17917/3THH-7C14</a></td><td>NIST-NCL Joint Assay Protocol, PCC-9: Determination of Gold in Rat Blood with Inductively Coupled Plasma Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130998.html>10.17917/0QDS-ZT72</a></td><td>NIST-NCL Joint Assay Protocol, PCC-10: Analysis of Gold Nanoparticles by Electrospray Differential Mobility Analysis (ES-DMA)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130999.html>10.17917/2ZKD-6321</a></td><td>NIST-NCL Joint Assay Protocol, PCC-11: Method for Determination of the Mass Fraction of Particle-Bound Gold in Suspensions of Gold Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131000.html>10.17917/9Q5G-G245</a></td><td>NIST-NCL Joint Assay Protocol, PCC-12: Measuring the Electrolytic Conductivity of Nanoparticle Suspensions</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131001.html>10.17917/YNXM-AD40</a></td><td>NIST-NCL Joint Assay Protocol, PCC-13: Measuring the pH of Nanoparticle Suspensions</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131002.html>10.17917/NHEE-7838</a></td><td>NIST-NCL Joint Assay Protocol, PCC-15: Measuring the Size of Colloidal Gold Nano-particles using HighResolution Scanning Electron Microscopy</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131003.html>10.17917/X6PD-WC14</a></td><td>NIST-NCL Joint Assay Protocol, PCC-14: Quantification of Free and Chelated Gadolinium Species in Nanoemulsion-Based Magnetic Resonance Imaging Contrast Agent Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131004.html>10.17917/C75P4P</a></td><td>NCL Method PCC-23: Quantitation of Residual DMSO in Nanoformulations Using Gas Chromatography with Direct Injection and Flame Ionization Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131005.html>10.17917/2HFK-9E25 </a></td><td>NCL Method PHA-1: Radioactive Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131006.html>10.17917/8EJ1-9P65</a></td><td>NCL Method PHA-2: Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131007.html>10.17917/Q6EC-XC97 </a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131008.html>10.17917/96Z2-NZ61</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131009.html> 10.17917/EHR9-HB86 </a></td><td>NCL Method GTA-3: Hep G2 Hepatocyte Glutathione Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131010.html>10.17917/H65D-SJ70</a></td><td>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131011.html>10.17917/E9YS-N327 </a></td><td>NCL Method GTA-5: LLC-PK1 Kidney Cell Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131012.html>10.17917/3F7T-M688 </a></td><td>NCL Method GTA-6: HepG2 Hepatocarcinoma Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131013.html>10.17917/0WF6-GX40 </a></td><td>NCL Method GTA-7: Hepatocyte Primary ROS Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131014.html>10.17917/WY7Z-MD10</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131015.html>10.17917/YPTH-N396 </a></td><td>NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131016.html>10.17917/95VC-ZP26</a></td><td>NCL Method GTA-14: Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131017.html>10.17917/T6JC-ZG30 </a></td><td>NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131018.html>10.17917/0YC3-6793</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131019.html>10.17917/Y4CQ-SV79</a></td><td>NCL Method ITA-26: Detection of Intracellular Complement Activation in Human T Lymphocytes</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131020.html>10.17917/PRQZ-3095</a></td><td>NCL Method ITA-31: Detection of Nanoparticle-Mediated Total Oxidative Stress in T Cells Using CM-H2DC-FDA Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131021.html>10.17917/HWV7-3E78</a></td><td>NCL Method ITA-32: Detection of Mitochondrial Oxidative Stress in T Cells Using MitoSOX Red Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131022.html>10.17917/RTMF-4853</a></td><td>NCL Method ITA-33: Detection of Changes in Mitochondrial Membrane Potential in T Cells Using JC-1 Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131023.html>10.17917/YTEJ-F575</a></td><td>NCL Method ITA-34: Detection of Antigen Presentation by Murine Bone Marrow-Derived Dendritic Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131024.html>10.17917/1QRB-NC62</a></td><td>NCL Method ITA-35: Antigen-Specific Stimulation of CD8+ T Cells by Murine Bone Marrow-Derived Dendritic Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131059.html>10.17917/A20K-T950</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131060.html>10.17917/VZ9M-8351</a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131061.html>10.17917/MQJP-YG07</a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131062.html>10.17917/P9TT-MN30</a></td><td>NCL Method STE-2.1: Detection of Microbial Contamination Using Millipore Sampler Devices</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131063.html>10.17917/5JCE-HQ72</a></td><td>NCL Method STE-2.2: Detection of Bacterial Contamination Using Luria Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131064.html>10.17917/QCFR-6F07</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131065.html>10.17917/916B-JQ80</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131066.html>10.17917/54TK-DG93</a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131067.html>10.17917/XCBE-2712</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131068.html>10.17917/R1XZ-X580</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131069.html>10.17917/8XN0-3373</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131070.html>10.17917/71WC-AN25</a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131071.html>10.17917/NF9V-MM03</a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131072.html>10.17917/MP68-WN76</a></td><td>Supplement to NIST-NCL Joint Assay Protocols PCC-8 & PCC-9: Metal Quantitation by Inductively Coupled Plasma-Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131073.html>10.17917/Y597-RM86</a></td><td>NCL Method PCC-16: Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131074.html>10.17917/QATM-6Q97</a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131075.html>10.17917/5NNX-F760</a></td><td>NCL Method PCC-18: Quantitation of APIs in Polymeric Prodrug Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131076.html>10.17917/RW1F-4D43</a></td><td>NCL Method PCC-19: Asymmetric-Flow Field-Flow Fractionation</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131077.html>10.17917/XQ3B-W012</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131078.html>10.17917/K0XB-3581</a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131079.html>10.17917/XJ16-D110</a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131080.html>10.17917/MK26-YD70</a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131081.html>10.17917/1GSW-5N64</a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131082.html>10.17917/2MDV-2445</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131083.html>10.17917/W9YH-YJ13</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131084.html>10.17917/DQZP-7M50</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131085.html>10.17917/0ZHD-SA93</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131086.html>10.17917/4G01-8T87</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131087.html>10.17917/3DE3-3446</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131088.html>10.17917/D0GG-4X14</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131089.html>10.17917/6J6H-3R27</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131090.html>10.17917/WRWV-CW04</a></td><td>NCL Method ITA-5.2: Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131091.html>10.17917/4VDA-ZS32</a></td><td>NCL Method ITA-6: Leukocyte Proliferation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131092.html>10.17917/SX37-3D76</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131093.html>10.17917/NB97-6E21</a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131094.html>10.17917/X2P6-HA51</a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131095.html>10.17917/Q94Q-6B29</a></td><td>NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131096.html>10.17917/W604-T506</a></td><td>NCL Method ITA-8: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131097.html>10.17917/K08Q-Y828</a></td><td>NCL Method ITA-8.1: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131098.html>10.17917/CFBS-5C02</a></td><td>NCL Method ITA-8.2: Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131099.html>10.17917/NQK3-2449</a></td><td>NCL Method ITA-9: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131100.html>10.17917/P4YG-Z672</a></td><td>NCL Method ITA-9.1: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131101.html>10.17917/RXJ2-EG43</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131102.html>10.17917/HVEG-VH85</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131103.html>10.17917/F4CE-FT82</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131104.html>10.17917/2DT9-XS67</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131105.html>10.17917/P6SK-3R71</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131106.html>10.17917/GV9W-FF90</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131107.html>10.17917/72F3-8Z52</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131108.html>10.17917/AJ1Z-2E64</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131109.html>10.17917/NK3Y-2F88</a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131110.html>10.17917/F32N-3W57</a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131111.html>10.17917/C59D-T717</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131112.html>10.17917/3429-7641</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131113.html>10.17917/DKY3-BZ13</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131114.html>10.17917/EWMJ-D959</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131115.html>10.17917/PQVY-GN53</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131116.html>10.17917/BHQ7-GD40</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131117.html>10.17917/X900-GP60</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131118.html>10.17917/S3CM-4J74</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131119.html>10.17917/ZXVG-DA66</a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131120.html>10.17917/ZNS7-4E84</a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131121.html>10.17917/D4XK-WH24</a></td><td>NCL Method ITA-27: Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131122.html>10.17917/E65B-GP64</a></td><td>NCL Method ITA-29: Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131123.html>10.17917/06V6-WD77</a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131124.html>10.17917/1RPW-X912</a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131125.html>10.17917/GJ0C-JY85</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131126.html>10.17917/8FKW-D647</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131127.html>10.17917/8BPC-VN29</a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131128.html>10.17917/SGVV-N363</a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131129.html>10.17917/NG6J-WH37</a></td><td>NCL Method ITA-40: Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131130.html>10.17917/WPJB-EE02</a></td><td>NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131131.html>10.17917/5S8G-WB35</a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131132.html>10.17917/WV7C-JG27</a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131133.html>10.17917/BFZH-QN35</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131134.html>10.17917/DWFK-8B95</a></td><td>NCL Method GTA-3: Hep G2 Hepatocyte Glutathione Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131135.html>10.17917/NGR4-KR46</a></td><td>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131136.html>10.17917/J2HN-5116</a></td><td>NCL Method GTA-5: LLC-PK1 Kidney Cell Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131137.html>10.17917/RJYY-4562</a></td><td>NCL Method GTA-6: HepG2 Hepatocarcinoma Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131138.html>10.17917/PP52-SF51</a></td><td>NCL Method GTA-7: Hepatocyte Primary ROS Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131139.html>10.17917/BAWN-K053</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131140.html>10.17917/F3HK-FC87</a></td><td>NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131141.html>10.17917/ZMDT-FP49</a></td><td>NCL Method GTA-13: In Vitro Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131142.html>10.17917/BPA7-XK19</a></td><td>NCL Method GTA-14: Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131143.html>10.17917/P2B0-5211</a></td><td>NCL Method PHA-1: Radioactive Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131144.html>10.17917/97H6-ZZ07</a></td><td>NCL Method PHA-2: Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131146.html>10.17917/0DFX-GC30</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131147.html>10.17917/6KEP-3R19</a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131148.html>10.17917/373S-6W98</a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131149.html>10.17917/2EEV-MY50</a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131150.html>10.17917/C73S3Q</a></td><td>NIST-NCL Joint Assay Protocol, PCC-11: Method for Determination of the Mass Fraction of Particle-Bound Gold in Suspensions of Gold Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131151.html>10.17917/C73W2C </a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131152.html>10.17917/C74D4M</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131153.html>10.17917/C7201Q</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Liposomal Products</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131154.html>10.17917/C73011</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Colloidal Metal Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131155.html>10.17917/C76P40</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Polymeric Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131156.html>10.17917/GS4R-4H02</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131157.html>10.17917/NZYM-3K29</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131158.html>10.17917/PJNB-JJ95</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131159.html>10.17917/C70013</a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131160.html>10.17917/C7059V</a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131161.html>10.17917/C7G596</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131162.html>10.17917/C7J012</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131163.html>10.17917/C7BC78</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131164.html>10.17917/C77P49</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131165.html>10.17917/C7PP4B </a></td><td>Endotoxin and Depyrogenation Guide</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131166.html>10.17917/C7NP41</a></td><td>NCL Method ITA-38: Analysis of Nanoparticle Effects on IgE-Dependent Mast Cell Degranulation </td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131167.html>10.17917/BND8-T188</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131197.html>10.17917/WZGC-DG48</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539136.html>10.17917/ZB8P-FB40 </a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539138.html>10.17917/1VHC-MJ13 </a></td><td>NCL Method PCC-16: Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539139.html>10.17917/JM45-VA25</a></td><td>NCL Method PCC-18: Quantitation of APIs in Polymeric Prodrug Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539140.html>10.17917/8S1D-BN17 </a></td><td>NCL Method PCC-19: Asymmetric-Flow Field-Flow Fractionation</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539141.html>10.17917/WF0H-1V72 </a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539142.html>10.17917/V9AP-D094 </a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539143.html>10.17917/0165-RC67 </a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539144.html>10.17917/7GEJ-8G77</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539145.html>10.17917/YTHD-KF51</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539146.html>10.17917/822G-S949 </a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539147.html>10.17917/HA0Q-5B49</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539148.html>10.17917/EQCT-3C51</a></td><td>NCL Method ITA-5.2: Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539149.html>10.17917/C8XW-BQ05</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834048.html>10.17917/B68Q-T959</a></td><td>Supplement to NIST-NCL Joint Assay Protocols PCC-8 & PCC-9: Metal Quantitation by Inductively Coupled Plasma-Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834054.html>10.17917/WBSK-2W04 </a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834056.html>10.17917/GS4C-N171</a></td><td>NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834057.html>10.17917/M173-MY22  </a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834059.html>10.17917/QENR-XG24</a></td><td>NCL Method ITA-8.2: Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834060.html>10.17917/CPWX-SP39</a></td><td>NCL Method ITA-8.1: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834061.html>10.17917/ZTXV-XC08</a></td><td>NCL Method ITA-9.1: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834062.html>10.17917/WZGC-DG48</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834063.html>10.17917/GBQR-BN14</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834064.html>10.17917/416C-5429 </a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834065.html>10.17917/7SF3-7A88</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834066.html>10.17917/ZQ6R-KD69 </a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834067.html>10.17917/GMXG-BH29</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834068.html>10.17917/RD78-BZ75</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834069.html>10.17917/JQM0-0G48</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834070.html>10.17917/SJT2-7P72</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834071.html>10.17917/DM9W-8430 </a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/100335618.html>10.17917/P2T3-8P84</a></td><td>NCL Method ITA-27: Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/110788608.html>10.17917/30CJ-2J27 </a></td><td>NCL Method STE-2.2: Detection of Bacterial Contamination Using Luria Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/112853000.html>10.17917/DVJF-SS25 </a></td><td>NCL Method STE-2.1: Detection of Microbial Contamination Using Millipore Sampler Devices</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130946.html>10.17917/WFT5-1J52 </a></td><td>NCL Method STE-2.3: Detection of Bacterial Contamination Using Tryptic Soy Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130947.html>10.17917/86Y9-3Y16 </a></td><td>NCL Method STE-2.4: Detection of Bacterial Contamination using Tryptic Soy Agar Plates and RPMI Suspension Tests for the Purposes of Determining Bacterial ID</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130949.html>10.17917/G780-R621</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130950.html>10.17917/SCP8-6P58</a></td><td>NCL Method PCC-21: Measuring Size and Number Concentration of Metallic Nanoparticles using SP-ICP-MS</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130951.html>10.17917/QFEP-HD46</a></td><td>NCL Method PCC-22: Residual Organic Solvent Analysis in Nanoformulations Using Headspace Gas Chromatography</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130952.html>10.17917/7Z55-SJ80</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130954.html>10.17917/B5N6-F154</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Liposomal Products</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130955.html>10.17917/2MYC-DE76</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Colloidal Metal Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130956.html>10.17917/G13J-XR95</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Polymeric Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130957.html>10.17917/W63A-GR02 </a></td><td>Guide to NCL In Vivo Studies: Efficacy, Pharmacokinetics and Toxicology</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130958.html>10.17917/PBZB-N042 </a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130959.html> 10.17917/EYQD-3T61 </a></td><td>NCL Method ITA-29: Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130960.html>10.17917/C7K01C</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130961.html>10.17917/C7KW2Q </a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130962.html>10.17917/0J6M-EJ19 </a></td><td>NCL Method ITA-40: Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130963.html>10.17917/BA6D-TE29</a></td><td>NCL Method STE-4: Detection of Œ?-glucan contamination</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130988.html>10.17917/PHFP-8573 </a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130989.html>10.17917/B6HB-C950 </a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130990.html>10.17917/VRHF-5Y74 </a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130991.html>10.17917/RK6R-P820 </a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130992.html>10.17917/5WSQ-7X78</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130993.html>10.17917/3F5S-6728</a></td><td>NIST-NCL Joint Assay Protocol, PCC-1: Measuring the Size of Nanoparticles in Aqueous Media Using Batch-Mode Dynamic Light Scattering</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130994.html>10.17917/DHAG-PC35</a></td><td>NIST-NCL Joint Assay Protocol, PCC-6: Size Measurement of Nanoparticles Using Atomic Force Microscopy</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130995.html>10.17917/C7N7-N938</a></td><td>NIST-NCL Joint Assay Protocol, PCC-7: Measuring the Size of Nanoparticles Using Transmission Electron Microscopy (TEM)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130996.html>10.17917/SA6R-9D63</a></td><td>NIST-NCL Joint Assay Protocol, PCC-8: Determination of Gold in Rat Tissue with Inductively Coupled Plasma Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130997.html>10.17917/3THH-7C14</a></td><td>NIST-NCL Joint Assay Protocol, PCC-9: Determination of Gold in Rat Blood with Inductively Coupled Plasma Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130998.html>10.17917/0QDS-ZT72</a></td><td>NIST-NCL Joint Assay Protocol, PCC-10: Analysis of Gold Nanoparticles by Electrospray Differential Mobility Analysis (ES-DMA)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130999.html>10.17917/2ZKD-6321</a></td><td>NIST-NCL Joint Assay Protocol, PCC-11: Method for Determination of the Mass Fraction of Particle-Bound Gold in Suspensions of Gold Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131000.html>10.17917/9Q5G-G245</a></td><td>NIST-NCL Joint Assay Protocol, PCC-12: Measuring the Electrolytic Conductivity of Nanoparticle Suspensions</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131001.html>10.17917/YNXM-AD40</a></td><td>NIST-NCL Joint Assay Protocol, PCC-13: Measuring the pH of Nanoparticle Suspensions</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131002.html>10.17917/NHEE-7838</a></td><td>NIST-NCL Joint Assay Protocol, PCC-15: Measuring the Size of Colloidal Gold Nano-particles using HighResolution Scanning Electron Microscopy</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131003.html>10.17917/X6PD-WC14</a></td><td>NIST-NCL Joint Assay Protocol, PCC-14: Quantification of Free and Chelated Gadolinium Species in Nanoemulsion-Based Magnetic Resonance Imaging Contrast Agent Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131004.html>10.17917/C75P4P</a></td><td>NCL Method PCC-23: Quantitation of Residual DMSO in Nanoformulations Using Gas Chromatography with Direct Injection and Flame Ionization Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131005.html>10.17917/2HFK-9E25 </a></td><td>NCL Method PHA-1: Radioactive Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131006.html>10.17917/8EJ1-9P65</a></td><td>NCL Method PHA-2: Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131007.html>10.17917/Q6EC-XC97 </a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131008.html>10.17917/96Z2-NZ61</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131009.html> 10.17917/EHR9-HB86 </a></td><td>NCL Method GTA-3: Hep G2 Hepatocyte Glutathione Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131010.html>10.17917/H65D-SJ70</a></td><td>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131011.html>10.17917/E9YS-N327 </a></td><td>NCL Method GTA-5: LLC-PK1 Kidney Cell Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131012.html>10.17917/3F7T-M688 </a></td><td>NCL Method GTA-6: HepG2 Hepatocarcinoma Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131013.html>10.17917/0WF6-GX40 </a></td><td>NCL Method GTA-7: Hepatocyte Primary ROS Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131014.html>10.17917/WY7Z-MD10</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131015.html>10.17917/YPTH-N396 </a></td><td>NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131016.html>10.17917/95VC-ZP26</a></td><td>NCL Method GTA-14: Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131017.html>10.17917/T6JC-ZG30 </a></td><td>NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131018.html>10.17917/0YC3-6793</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131019.html>10.17917/Y4CQ-SV79</a></td><td>NCL Method ITA-26: Detection of Intracellular Complement Activation in Human T Lymphocytes</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131020.html>10.17917/PRQZ-3095</a></td><td>NCL Method ITA-31: Detection of Nanoparticle-Mediated Total Oxidative Stress in T Cells Using CM-H2DC-FDA Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131021.html>10.17917/HWV7-3E78</a></td><td>NCL Method ITA-32: Detection of Mitochondrial Oxidative Stress in T Cells Using MitoSOX Red Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131022.html>10.17917/RTMF-4853</a></td><td>NCL Method ITA-33: Detection of Changes in Mitochondrial Membrane Potential in T Cells Using JC-1 Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131023.html>10.17917/YTEJ-F575</a></td><td>NCL Method ITA-34: Detection of Antigen Presentation by Murine Bone Marrow-Derived Dendritic Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131024.html>10.17917/1QRB-NC62</a></td><td>NCL Method ITA-35: Antigen-Specific Stimulation of CD8+ T Cells by Murine Bone Marrow-Derived Dendritic Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131059.html>10.17917/A20K-T950</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131060.html>10.17917/VZ9M-8351</a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131061.html>10.17917/MQJP-YG07</a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131062.html>10.17917/P9TT-MN30</a></td><td>NCL Method STE-2.1: Detection of Microbial Contamination Using Millipore Sampler Devices</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131063.html>10.17917/5JCE-HQ72</a></td><td>NCL Method STE-2.2: Detection of Bacterial Contamination Using Luria Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131064.html>10.17917/QCFR-6F07</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131065.html>10.17917/916B-JQ80</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131066.html>10.17917/54TK-DG93</a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131067.html>10.17917/XCBE-2712</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131068.html>10.17917/R1XZ-X580</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131069.html>10.17917/8XN0-3373</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131070.html>10.17917/71WC-AN25</a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131071.html>10.17917/NF9V-MM03</a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131072.html>10.17917/MP68-WN76</a></td><td>Supplement to NIST-NCL Joint Assay Protocols PCC-8 & PCC-9: Metal Quantitation by Inductively Coupled Plasma-Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131073.html>10.17917/Y597-RM86</a></td><td>NCL Method PCC-16: Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131074.html>10.17917/QATM-6Q97</a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131075.html>10.17917/5NNX-F760</a></td><td>NCL Method PCC-18: Quantitation of APIs in Polymeric Prodrug Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131076.html>10.17917/RW1F-4D43</a></td><td>NCL Method PCC-19: Asymmetric-Flow Field-Flow Fractionation</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131077.html>10.17917/XQ3B-W012</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131078.html>10.17917/K0XB-3581</a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131079.html>10.17917/XJ16-D110</a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131080.html>10.17917/MK26-YD70</a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131081.html>10.17917/1GSW-5N64</a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131082.html>10.17917/2MDV-2445</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131083.html>10.17917/W9YH-YJ13</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131084.html>10.17917/DQZP-7M50</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131085.html>10.17917/0ZHD-SA93</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131086.html>10.17917/4G01-8T87</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131087.html>10.17917/3DE3-3446</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131088.html>10.17917/D0GG-4X14</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131089.html>10.17917/6J6H-3R27</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131090.html>10.17917/WRWV-CW04</a></td><td>NCL Method ITA-5.2: Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131091.html>10.17917/4VDA-ZS32</a></td><td>NCL Method ITA-6: Leukocyte Proliferation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131092.html>10.17917/SX37-3D76</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131093.html>10.17917/NB97-6E21</a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131094.html>10.17917/X2P6-HA51</a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131095.html>10.17917/Q94Q-6B29</a></td><td>NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131096.html>10.17917/W604-T506</a></td><td>NCL Method ITA-8: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131097.html>10.17917/K08Q-Y828</a></td><td>NCL Method ITA-8.1: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131098.html>10.17917/CFBS-5C02</a></td><td>NCL Method ITA-8.2: Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131099.html>10.17917/NQK3-2449</a></td><td>NCL Method ITA-9: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131100.html>10.17917/P4YG-Z672</a></td><td>NCL Method ITA-9.1: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131101.html>10.17917/RXJ2-EG43</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131102.html>10.17917/HVEG-VH85</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131103.html>10.17917/F4CE-FT82</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131104.html>10.17917/2DT9-XS67</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131105.html>10.17917/P6SK-3R71</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131106.html>10.17917/GV9W-FF90</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131107.html>10.17917/72F3-8Z52</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131108.html>10.17917/AJ1Z-2E64</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131109.html>10.17917/NK3Y-2F88</a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131110.html>10.17917/F32N-3W57</a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131111.html>10.17917/C59D-T717</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131112.html>10.17917/3429-7641</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131113.html>10.17917/DKY3-BZ13</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131114.html>10.17917/EWMJ-D959</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131115.html>10.17917/PQVY-GN53</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131116.html>10.17917/BHQ7-GD40</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131117.html>10.17917/X900-GP60</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131118.html>10.17917/S3CM-4J74</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131119.html>10.17917/ZXVG-DA66</a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131120.html>10.17917/ZNS7-4E84</a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131121.html>10.17917/D4XK-WH24</a></td><td>NCL Method ITA-27: Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131122.html>10.17917/E65B-GP64</a></td><td>NCL Method ITA-29: Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131123.html>10.17917/06V6-WD77</a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131124.html>10.17917/1RPW-X912</a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131125.html>10.17917/GJ0C-JY85</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131126.html>10.17917/8FKW-D647</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131127.html>10.17917/8BPC-VN29</a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131128.html>10.17917/SGVV-N363</a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131129.html>10.17917/NG6J-WH37</a></td><td>NCL Method ITA-40: Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131130.html>10.17917/WPJB-EE02</a></td><td>NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131131.html>10.17917/5S8G-WB35</a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131132.html>10.17917/WV7C-JG27</a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131133.html>10.17917/BFZH-QN35</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131134.html>10.17917/DWFK-8B95</a></td><td>NCL Method GTA-3: Hep G2 Hepatocyte Glutathione Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131135.html>10.17917/NGR4-KR46</a></td><td>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131136.html>10.17917/J2HN-5116</a></td><td>NCL Method GTA-5: LLC-PK1 Kidney Cell Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131137.html>10.17917/RJYY-4562</a></td><td>NCL Method GTA-6: HepG2 Hepatocarcinoma Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131138.html>10.17917/PP52-SF51</a></td><td>NCL Method GTA-7: Hepatocyte Primary ROS Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131139.html>10.17917/BAWN-K053</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131140.html>10.17917/F3HK-FC87</a></td><td>NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131141.html>10.17917/ZMDT-FP49</a></td><td>NCL Method GTA-13: In Vitro Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131142.html>10.17917/BPA7-XK19</a></td><td>NCL Method GTA-14: Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131143.html>10.17917/P2B0-5211</a></td><td>NCL Method PHA-1: Radioactive Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131144.html>10.17917/97H6-ZZ07</a></td><td>NCL Method PHA-2: Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131146.html>10.17917/0DFX-GC30</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131147.html>10.17917/6KEP-3R19</a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131148.html>10.17917/373S-6W98</a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131149.html>10.17917/2EEV-MY50</a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131150.html>10.17917/C73S3Q</a></td><td>NIST-NCL Joint Assay Protocol, PCC-11: Method for Determination of the Mass Fraction of Particle-Bound Gold in Suspensions of Gold Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131151.html>10.17917/C73W2C </a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131152.html>10.17917/C74D4M</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131153.html>10.17917/C7201Q</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Liposomal Products</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131154.html>10.17917/C73011</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Colloidal Metal Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131155.html>10.17917/C76P40</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Polymeric Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131156.html>10.17917/GS4R-4H02</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131157.html>10.17917/NZYM-3K29</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131158.html>10.17917/PJNB-JJ95</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131159.html>10.17917/C70013</a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131160.html>10.17917/C7059V</a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131161.html>10.17917/C7G596</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131162.html>10.17917/C7J012</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131163.html>10.17917/C7BC78</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131164.html>10.17917/C77P49</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131165.html>10.17917/C7PP4B </a></td><td>Endotoxin and Depyrogenation Guide</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131166.html>10.17917/C7NP41</a></td><td>NCL Method ITA-38: Analysis of Nanoparticle Effects on IgE-Dependent Mast Cell Degranulation </td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131167.html>10.17917/BND8-T188</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131197.html>10.17917/WZGC-DG48</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539136.html>10.17917/ZB8P-FB40 </a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539138.html>10.17917/1VHC-MJ13 </a></td><td>NCL Method PCC-16: Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539139.html>10.17917/JM45-VA25</a></td><td>NCL Method PCC-18: Quantitation of APIs in Polymeric Prodrug Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539140.html>10.17917/8S1D-BN17 </a></td><td>NCL Method PCC-19: Asymmetric-Flow Field-Flow Fractionation</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539141.html>10.17917/WF0H-1V72 </a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539142.html>10.17917/V9AP-D094 </a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539143.html>10.17917/0165-RC67 </a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539144.html>10.17917/7GEJ-8G77</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539145.html>10.17917/YTHD-KF51</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539146.html>10.17917/822G-S949 </a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539147.html>10.17917/HA0Q-5B49</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539148.html>10.17917/EQCT-3C51</a></td><td>NCL Method ITA-5.2: Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539149.html>10.17917/C8XW-BQ05</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834048.html>10.17917/B68Q-T959</a></td><td>Supplement to NIST-NCL Joint Assay Protocols PCC-8 & PCC-9: Metal Quantitation by Inductively Coupled Plasma-Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834054.html>10.17917/WBSK-2W04 </a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834056.html>10.17917/GS4C-N171</a></td><td>NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834057.html>10.17917/M173-MY22  </a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834059.html>10.17917/QENR-XG24</a></td><td>NCL Method ITA-8.2: Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834060.html>10.17917/CPWX-SP39</a></td><td>NCL Method ITA-8.1: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834061.html>10.17917/ZTXV-XC08</a></td><td>NCL Method ITA-9.1: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834062.html>10.17917/WZGC-DG48</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834063.html>10.17917/GBQR-BN14</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834064.html>10.17917/416C-5429 </a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834065.html>10.17917/7SF3-7A88</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834066.html>10.17917/ZQ6R-KD69 </a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834067.html>10.17917/GMXG-BH29</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834068.html>10.17917/RD78-BZ75</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834069.html>10.17917/JQM0-0G48</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834070.html>10.17917/SJT2-7P72</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834071.html>10.17917/DM9W-8430 </a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/100335618.html>10.17917/P2T3-8P84</a></td><td>NCL Method ITA-27: Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/110788608.html>10.17917/30CJ-2J27 </a></td><td>NCL Method STE-2.2: Detection of Bacterial Contamination Using Luria Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/112853000.html>10.17917/DVJF-SS25 </a></td><td>NCL Method STE-2.1: Detection of Microbial Contamination Using Millipore Sampler Devices</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130946.html>10.17917/WFT5-1J52 </a></td><td>NCL Method STE-2.3: Detection of Bacterial Contamination Using Tryptic Soy Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130947.html>10.17917/86Y9-3Y16 </a></td><td>NCL Method STE-2.4: Detection of Bacterial Contamination using Tryptic Soy Agar Plates and RPMI Suspension Tests for the Purposes of Determining Bacterial ID</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130949.html>10.17917/G780-R621</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130950.html>10.17917/SCP8-6P58</a></td><td>NCL Method PCC-21: Measuring Size and Number Concentration of Metallic Nanoparticles using SP-ICP-MS</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130951.html>10.17917/QFEP-HD46</a></td><td>NCL Method PCC-22: Residual Organic Solvent Analysis in Nanoformulations Using Headspace Gas Chromatography</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130952.html>10.17917/7Z55-SJ80</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130954.html>10.17917/B5N6-F154</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Liposomal Products</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130955.html>10.17917/2MYC-DE76</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Colloidal Metal Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130956.html>10.17917/G13J-XR95</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Polymeric Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130957.html>10.17917/W63A-GR02 </a></td><td>Guide to NCL In Vivo Studies: Efficacy, Pharmacokinetics and Toxicology</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130958.html>10.17917/PBZB-N042 </a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130959.html> 10.17917/EYQD-3T61 </a></td><td>NCL Method ITA-29: Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130960.html>10.17917/C7K01C</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130961.html>10.17917/C7KW2Q </a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130962.html>10.17917/0J6M-EJ19 </a></td><td>NCL Method ITA-40: Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130963.html>10.17917/BA6D-TE29</a></td><td>NCL Method STE-4: Detection of Œ?-glucan contamination</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130988.html>10.17917/PHFP-8573 </a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130989.html>10.17917/B6HB-C950 </a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130990.html>10.17917/VRHF-5Y74 </a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130991.html>10.17917/RK6R-P820 </a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130992.html>10.17917/5WSQ-7X78</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130993.html>10.17917/3F5S-6728</a></td><td>NIST-NCL Joint Assay Protocol, PCC-1: Measuring the Size of Nanoparticles in Aqueous Media Using Batch-Mode Dynamic Light Scattering</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130994.html>10.17917/DHAG-PC35</a></td><td>NIST-NCL Joint Assay Protocol, PCC-6: Size Measurement of Nanoparticles Using Atomic Force Microscopy</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130995.html>10.17917/C7N7-N938</a></td><td>NIST-NCL Joint Assay Protocol, PCC-7: Measuring the Size of Nanoparticles Using Transmission Electron Microscopy (TEM)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130996.html>10.17917/SA6R-9D63</a></td><td>NIST-NCL Joint Assay Protocol, PCC-8: Determination of Gold in Rat Tissue with Inductively Coupled Plasma Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130997.html>10.17917/3THH-7C14</a></td><td>NIST-NCL Joint Assay Protocol, PCC-9: Determination of Gold in Rat Blood with Inductively Coupled Plasma Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130998.html>10.17917/0QDS-ZT72</a></td><td>NIST-NCL Joint Assay Protocol, PCC-10: Analysis of Gold Nanoparticles by Electrospray Differential Mobility Analysis (ES-DMA)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130999.html>10.17917/2ZKD-6321</a></td><td>NIST-NCL Joint Assay Protocol, PCC-11: Method for Determination of the Mass Fraction of Particle-Bound Gold in Suspensions of Gold Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131000.html>10.17917/9Q5G-G245</a></td><td>NIST-NCL Joint Assay Protocol, PCC-12: Measuring the Electrolytic Conductivity of Nanoparticle Suspensions</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131001.html>10.17917/YNXM-AD40</a></td><td>NIST-NCL Joint Assay Protocol, PCC-13: Measuring the pH of Nanoparticle Suspensions</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131002.html>10.17917/NHEE-7838</a></td><td>NIST-NCL Joint Assay Protocol, PCC-15: Measuring the Size of Colloidal Gold Nano-particles using HighResolution Scanning Electron Microscopy</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131003.html>10.17917/X6PD-WC14</a></td><td>NIST-NCL Joint Assay Protocol, PCC-14: Quantification of Free and Chelated Gadolinium Species in Nanoemulsion-Based Magnetic Resonance Imaging Contrast Agent Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131004.html>10.17917/C75P4P</a></td><td>NCL Method PCC-23: Quantitation of Residual DMSO in Nanoformulations Using Gas Chromatography with Direct Injection and Flame Ionization Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131005.html>10.17917/2HFK-9E25 </a></td><td>NCL Method PHA-1: Radioactive Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131006.html>10.17917/8EJ1-9P65</a></td><td>NCL Method PHA-2: Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131007.html>10.17917/Q6EC-XC97 </a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131008.html>10.17917/96Z2-NZ61</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131009.html> 10.17917/EHR9-HB86 </a></td><td>NCL Method GTA-3: Hep G2 Hepatocyte Glutathione Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131010.html>10.17917/H65D-SJ70</a></td><td>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131011.html>10.17917/E9YS-N327 </a></td><td>NCL Method GTA-5: LLC-PK1 Kidney Cell Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131012.html>10.17917/3F7T-M688 </a></td><td>NCL Method GTA-6: HepG2 Hepatocarcinoma Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131013.html>10.17917/0WF6-GX40 </a></td><td>NCL Method GTA-7: Hepatocyte Primary ROS Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131014.html>10.17917/WY7Z-MD10</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131015.html>10.17917/YPTH-N396 </a></td><td>NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131016.html>10.17917/95VC-ZP26</a></td><td>NCL Method GTA-14: Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131017.html>10.17917/T6JC-ZG30 </a></td><td>NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131018.html>10.17917/0YC3-6793</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131019.html>10.17917/Y4CQ-SV79</a></td><td>NCL Method ITA-26: Detection of Intracellular Complement Activation in Human T Lymphocytes</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131020.html>10.17917/PRQZ-3095</a></td><td>NCL Method ITA-31: Detection of Nanoparticle-Mediated Total Oxidative Stress in T Cells Using CM-H2DC-FDA Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131021.html>10.17917/HWV7-3E78</a></td><td>NCL Method ITA-32: Detection of Mitochondrial Oxidative Stress in T Cells Using MitoSOX Red Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131022.html>10.17917/RTMF-4853</a></td><td>NCL Method ITA-33: Detection of Changes in Mitochondrial Membrane Potential in T Cells Using JC-1 Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131023.html>10.17917/YTEJ-F575</a></td><td>NCL Method ITA-34: Detection of Antigen Presentation by Murine Bone Marrow-Derived Dendritic Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131024.html>10.17917/1QRB-NC62</a></td><td>NCL Method ITA-35: Antigen-Specific Stimulation of CD8+ T Cells by Murine Bone Marrow-Derived Dendritic Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131059.html>10.17917/A20K-T950</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131060.html>10.17917/VZ9M-8351</a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131061.html>10.17917/MQJP-YG07</a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131062.html>10.17917/P9TT-MN30</a></td><td>NCL Method STE-2.1: Detection of Microbial Contamination Using Millipore Sampler Devices</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131063.html>10.17917/5JCE-HQ72</a></td><td>NCL Method STE-2.2: Detection of Bacterial Contamination Using Luria Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131064.html>10.17917/QCFR-6F07</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131065.html>10.17917/916B-JQ80</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131066.html>10.17917/54TK-DG93</a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131067.html>10.17917/XCBE-2712</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131068.html>10.17917/R1XZ-X580</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131069.html>10.17917/8XN0-3373</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131070.html>10.17917/71WC-AN25</a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131071.html>10.17917/NF9V-MM03</a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131072.html>10.17917/MP68-WN76</a></td><td>Supplement to NIST-NCL Joint Assay Protocols PCC-8 & PCC-9: Metal Quantitation by Inductively Coupled Plasma-Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131073.html>10.17917/Y597-RM86</a></td><td>NCL Method PCC-16: Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131074.html>10.17917/QATM-6Q97</a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131075.html>10.17917/5NNX-F760</a></td><td>NCL Method PCC-18: Quantitation of APIs in Polymeric Prodrug Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131076.html>10.17917/RW1F-4D43</a></td><td>NCL Method PCC-19: Asymmetric-Flow Field-Flow Fractionation</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131077.html>10.17917/XQ3B-W012</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131078.html>10.17917/K0XB-3581</a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131079.html>10.17917/XJ16-D110</a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131080.html>10.17917/MK26-YD70</a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131081.html>10.17917/1GSW-5N64</a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131082.html>10.17917/2MDV-2445</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131083.html>10.17917/W9YH-YJ13</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131084.html>10.17917/DQZP-7M50</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131085.html>10.17917/0ZHD-SA93</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131086.html>10.17917/4G01-8T87</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131087.html>10.17917/3DE3-3446</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131088.html>10.17917/D0GG-4X14</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131089.html>10.17917/6J6H-3R27</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131090.html>10.17917/WRWV-CW04</a></td><td>NCL Method ITA-5.2: Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131091.html>10.17917/4VDA-ZS32</a></td><td>NCL Method ITA-6: Leukocyte Proliferation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131092.html>10.17917/SX37-3D76</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131093.html>10.17917/NB97-6E21</a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131094.html>10.17917/X2P6-HA51</a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131095.html>10.17917/Q94Q-6B29</a></td><td>NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131096.html>10.17917/W604-T506</a></td><td>NCL Method ITA-8: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131097.html>10.17917/K08Q-Y828</a></td><td>NCL Method ITA-8.1: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131098.html>10.17917/CFBS-5C02</a></td><td>NCL Method ITA-8.2: Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131099.html>10.17917/NQK3-2449</a></td><td>NCL Method ITA-9: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131100.html>10.17917/P4YG-Z672</a></td><td>NCL Method ITA-9.1: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131101.html>10.17917/RXJ2-EG43</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131102.html>10.17917/HVEG-VH85</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131103.html>10.17917/F4CE-FT82</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131104.html>10.17917/2DT9-XS67</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131105.html>10.17917/P6SK-3R71</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131106.html>10.17917/GV9W-FF90</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131107.html>10.17917/72F3-8Z52</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131108.html>10.17917/AJ1Z-2E64</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131109.html>10.17917/NK3Y-2F88</a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131110.html>10.17917/F32N-3W57</a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131111.html>10.17917/C59D-T717</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131112.html>10.17917/3429-7641</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131113.html>10.17917/DKY3-BZ13</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131114.html>10.17917/EWMJ-D959</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131115.html>10.17917/PQVY-GN53</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131116.html>10.17917/BHQ7-GD40</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131117.html>10.17917/X900-GP60</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131118.html>10.17917/S3CM-4J74</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131119.html>10.17917/ZXVG-DA66</a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131120.html>10.17917/ZNS7-4E84</a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131121.html>10.17917/D4XK-WH24</a></td><td>NCL Method ITA-27: Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131122.html>10.17917/E65B-GP64</a></td><td>NCL Method ITA-29: Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131123.html>10.17917/06V6-WD77</a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131124.html>10.17917/1RPW-X912</a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131125.html>10.17917/GJ0C-JY85</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131126.html>10.17917/8FKW-D647</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131127.html>10.17917/8BPC-VN29</a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131128.html>10.17917/SGVV-N363</a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131129.html>10.17917/NG6J-WH37</a></td><td>NCL Method ITA-40: Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131130.html>10.17917/WPJB-EE02</a></td><td>NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131131.html>10.17917/5S8G-WB35</a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131132.html>10.17917/WV7C-JG27</a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131133.html>10.17917/BFZH-QN35</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131134.html>10.17917/DWFK-8B95</a></td><td>NCL Method GTA-3: Hep G2 Hepatocyte Glutathione Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131135.html>10.17917/NGR4-KR46</a></td><td>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131136.html>10.17917/J2HN-5116</a></td><td>NCL Method GTA-5: LLC-PK1 Kidney Cell Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131137.html>10.17917/RJYY-4562</a></td><td>NCL Method GTA-6: HepG2 Hepatocarcinoma Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131138.html>10.17917/PP52-SF51</a></td><td>NCL Method GTA-7: Hepatocyte Primary ROS Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131139.html>10.17917/BAWN-K053</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131140.html>10.17917/F3HK-FC87</a></td><td>NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131141.html>10.17917/ZMDT-FP49</a></td><td>NCL Method GTA-13: In Vitro Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131142.html>10.17917/BPA7-XK19</a></td><td>NCL Method GTA-14: Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131143.html>10.17917/P2B0-5211</a></td><td>NCL Method PHA-1: Radioactive Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131144.html>10.17917/97H6-ZZ07</a></td><td>NCL Method PHA-2: Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131146.html>10.17917/0DFX-GC30</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131147.html>10.17917/6KEP-3R19</a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131148.html>10.17917/373S-6W98</a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131149.html>10.17917/2EEV-MY50</a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131150.html>10.17917/C73S3Q</a></td><td>NIST-NCL Joint Assay Protocol, PCC-11: Method for Determination of the Mass Fraction of Particle-Bound Gold in Suspensions of Gold Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131151.html>10.17917/C73W2C </a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131152.html>10.17917/C74D4M</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131153.html>10.17917/C7201Q</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Liposomal Products</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131154.html>10.17917/C73011</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Colloidal Metal Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131155.html>10.17917/C76P40</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Polymeric Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131156.html>10.17917/GS4R-4H02</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131157.html>10.17917/NZYM-3K29</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131158.html>10.17917/PJNB-JJ95</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131159.html>10.17917/C70013</a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131160.html>10.17917/C7059V</a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131161.html>10.17917/C7G596</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131162.html>10.17917/C7J012</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131163.html>10.17917/C7BC78</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131164.html>10.17917/C77P49</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131165.html>10.17917/C7PP4B </a></td><td>Endotoxin and Depyrogenation Guide</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131166.html>10.17917/C7NP41</a></td><td>NCL Method ITA-38: Analysis of Nanoparticle Effects on IgE-Dependent Mast Cell Degranulation </td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131167.html>10.17917/BND8-T188</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131197.html>10.17917/WZGC-DG48</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539136.html>10.17917/ZB8P-FB40 </a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539138.html>10.17917/1VHC-MJ13 </a></td><td>NCL Method PCC-16: Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539139.html>10.17917/JM45-VA25</a></td><td>NCL Method PCC-18: Quantitation of APIs in Polymeric Prodrug Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539140.html>10.17917/8S1D-BN17 </a></td><td>NCL Method PCC-19: Asymmetric-Flow Field-Flow Fractionation</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539141.html>10.17917/WF0H-1V72 </a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539142.html>10.17917/V9AP-D094 </a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539143.html>10.17917/0165-RC67 </a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539144.html>10.17917/7GEJ-8G77</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539145.html>10.17917/YTHD-KF51</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539146.html>10.17917/822G-S949 </a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539147.html>10.17917/HA0Q-5B49</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539148.html>10.17917/EQCT-3C51</a></td><td>NCL Method ITA-5.2: Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539149.html>10.17917/C8XW-BQ05</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834048.html>10.17917/B68Q-T959</a></td><td>Supplement to NIST-NCL Joint Assay Protocols PCC-8 & PCC-9: Metal Quantitation by Inductively Coupled Plasma-Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834054.html>10.17917/WBSK-2W04 </a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834056.html>10.17917/GS4C-N171</a></td><td>NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834057.html>10.17917/M173-MY22  </a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834059.html>10.17917/QENR-XG24</a></td><td>NCL Method ITA-8.2: Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834060.html>10.17917/CPWX-SP39</a></td><td>NCL Method ITA-8.1: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834061.html>10.17917/ZTXV-XC08</a></td><td>NCL Method ITA-9.1: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834062.html>10.17917/WZGC-DG48</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834063.html>10.17917/GBQR-BN14</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834064.html>10.17917/416C-5429 </a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834065.html>10.17917/7SF3-7A88</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834066.html>10.17917/ZQ6R-KD69 </a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834067.html>10.17917/GMXG-BH29</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834068.html>10.17917/RD78-BZ75</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834069.html>10.17917/JQM0-0G48</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834070.html>10.17917/SJT2-7P72</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834071.html>10.17917/DM9W-8430 </a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/100335618.html>10.17917/P2T3-8P84</a></td><td>NCL Method ITA-27: Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/110788608.html>10.17917/30CJ-2J27 </a></td><td>NCL Method STE-2.2: Detection of Bacterial Contamination Using Luria Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/112853000.html>10.17917/DVJF-SS25 </a></td><td>NCL Method STE-2.1: Detection of Microbial Contamination Using Millipore Sampler Devices</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130946.html>10.17917/WFT5-1J52 </a></td><td>NCL Method STE-2.3: Detection of Bacterial Contamination Using Tryptic Soy Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130947.html>10.17917/86Y9-3Y16 </a></td><td>NCL Method STE-2.4: Detection of Bacterial Contamination using Tryptic Soy Agar Plates and RPMI Suspension Tests for the Purposes of Determining Bacterial ID</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130949.html>10.17917/G780-R621</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130950.html>10.17917/SCP8-6P58</a></td><td>NCL Method PCC-21: Measuring Size and Number Concentration of Metallic Nanoparticles using SP-ICP-MS</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130951.html>10.17917/QFEP-HD46</a></td><td>NCL Method PCC-22: Residual Organic Solvent Analysis in Nanoformulations Using Headspace Gas Chromatography</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130952.html>10.17917/7Z55-SJ80</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130954.html>10.17917/B5N6-F154</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Liposomal Products</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130955.html>10.17917/2MYC-DE76</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Colloidal Metal Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130956.html>10.17917/G13J-XR95</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Polymeric Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130957.html>10.17917/W63A-GR02 </a></td><td>Guide to NCL In Vivo Studies: Efficacy, Pharmacokinetics and Toxicology</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130958.html>10.17917/PBZB-N042 </a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130959.html> 10.17917/EYQD-3T61 </a></td><td>NCL Method ITA-29: Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130960.html>10.17917/C7K01C</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130961.html>10.17917/C7KW2Q </a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130962.html>10.17917/0J6M-EJ19 </a></td><td>NCL Method ITA-40: Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130963.html>10.17917/BA6D-TE29</a></td><td>NCL Method STE-4: Detection of Œ?-glucan contamination</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130988.html>10.17917/PHFP-8573 </a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130989.html>10.17917/B6HB-C950 </a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130990.html>10.17917/VRHF-5Y74 </a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130991.html>10.17917/RK6R-P820 </a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130992.html>10.17917/5WSQ-7X78</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130993.html>10.17917/3F5S-6728</a></td><td>NIST-NCL Joint Assay Protocol, PCC-1: Measuring the Size of Nanoparticles in Aqueous Media Using Batch-Mode Dynamic Light Scattering</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130994.html>10.17917/DHAG-PC35</a></td><td>NIST-NCL Joint Assay Protocol, PCC-6: Size Measurement of Nanoparticles Using Atomic Force Microscopy</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130995.html>10.17917/C7N7-N938</a></td><td>NIST-NCL Joint Assay Protocol, PCC-7: Measuring the Size of Nanoparticles Using Transmission Electron Microscopy (TEM)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130996.html>10.17917/SA6R-9D63</a></td><td>NIST-NCL Joint Assay Protocol, PCC-8: Determination of Gold in Rat Tissue with Inductively Coupled Plasma Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130997.html>10.17917/3THH-7C14</a></td><td>NIST-NCL Joint Assay Protocol, PCC-9: Determination of Gold in Rat Blood with Inductively Coupled Plasma Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130998.html>10.17917/0QDS-ZT72</a></td><td>NIST-NCL Joint Assay Protocol, PCC-10: Analysis of Gold Nanoparticles by Electrospray Differential Mobility Analysis (ES-DMA)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130999.html>10.17917/2ZKD-6321</a></td><td>NIST-NCL Joint Assay Protocol, PCC-11: Method for Determination of the Mass Fraction of Particle-Bound Gold in Suspensions of Gold Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131000.html>10.17917/9Q5G-G245</a></td><td>NIST-NCL Joint Assay Protocol, PCC-12: Measuring the Electrolytic Conductivity of Nanoparticle Suspensions</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131001.html>10.17917/YNXM-AD40</a></td><td>NIST-NCL Joint Assay Protocol, PCC-13: Measuring the pH of Nanoparticle Suspensions</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131002.html>10.17917/NHEE-7838</a></td><td>NIST-NCL Joint Assay Protocol, PCC-15: Measuring the Size of Colloidal Gold Nano-particles using HighResolution Scanning Electron Microscopy</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131003.html>10.17917/X6PD-WC14</a></td><td>NIST-NCL Joint Assay Protocol, PCC-14: Quantification of Free and Chelated Gadolinium Species in Nanoemulsion-Based Magnetic Resonance Imaging Contrast Agent Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131004.html>10.17917/C75P4P</a></td><td>NCL Method PCC-23: Quantitation of Residual DMSO in Nanoformulations Using Gas Chromatography with Direct Injection and Flame Ionization Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131005.html>10.17917/2HFK-9E25 </a></td><td>NCL Method PHA-1: Radioactive Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131006.html>10.17917/8EJ1-9P65</a></td><td>NCL Method PHA-2: Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131007.html>10.17917/Q6EC-XC97 </a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131008.html>10.17917/96Z2-NZ61</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131009.html> 10.17917/EHR9-HB86 </a></td><td>NCL Method GTA-3: Hep G2 Hepatocyte Glutathione Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131010.html>10.17917/H65D-SJ70</a></td><td>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131011.html>10.17917/E9YS-N327 </a></td><td>NCL Method GTA-5: LLC-PK1 Kidney Cell Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131012.html>10.17917/3F7T-M688 </a></td><td>NCL Method GTA-6: HepG2 Hepatocarcinoma Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131013.html>10.17917/0WF6-GX40 </a></td><td>NCL Method GTA-7: Hepatocyte Primary ROS Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131014.html>10.17917/WY7Z-MD10</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131015.html>10.17917/YPTH-N396 </a></td><td>NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131016.html>10.17917/95VC-ZP26</a></td><td>NCL Method GTA-14: Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131017.html>10.17917/T6JC-ZG30 </a></td><td>NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131018.html>10.17917/0YC3-6793</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131019.html>10.17917/Y4CQ-SV79</a></td><td>NCL Method ITA-26: Detection of Intracellular Complement Activation in Human T Lymphocytes</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131020.html>10.17917/PRQZ-3095</a></td><td>NCL Method ITA-31: Detection of Nanoparticle-Mediated Total Oxidative Stress in T Cells Using CM-H2DC-FDA Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131021.html>10.17917/HWV7-3E78</a></td><td>NCL Method ITA-32: Detection of Mitochondrial Oxidative Stress in T Cells Using MitoSOX Red Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131022.html>10.17917/RTMF-4853</a></td><td>NCL Method ITA-33: Detection of Changes in Mitochondrial Membrane Potential in T Cells Using JC-1 Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131023.html>10.17917/YTEJ-F575</a></td><td>NCL Method ITA-34: Detection of Antigen Presentation by Murine Bone Marrow-Derived Dendritic Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131024.html>10.17917/1QRB-NC62</a></td><td>NCL Method ITA-35: Antigen-Specific Stimulation of CD8+ T Cells by Murine Bone Marrow-Derived Dendritic Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131059.html>10.17917/A20K-T950</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131060.html>10.17917/VZ9M-8351</a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131061.html>10.17917/MQJP-YG07</a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131062.html>10.17917/P9TT-MN30</a></td><td>NCL Method STE-2.1: Detection of Microbial Contamination Using Millipore Sampler Devices</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131063.html>10.17917/5JCE-HQ72</a></td><td>NCL Method STE-2.2: Detection of Bacterial Contamination Using Luria Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131064.html>10.17917/QCFR-6F07</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131065.html>10.17917/916B-JQ80</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131066.html>10.17917/54TK-DG93</a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131067.html>10.17917/XCBE-2712</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131068.html>10.17917/R1XZ-X580</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131069.html>10.17917/8XN0-3373</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131070.html>10.17917/71WC-AN25</a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131071.html>10.17917/NF9V-MM03</a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131072.html>10.17917/MP68-WN76</a></td><td>Supplement to NIST-NCL Joint Assay Protocols PCC-8 & PCC-9: Metal Quantitation by Inductively Coupled Plasma-Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131073.html>10.17917/Y597-RM86</a></td><td>NCL Method PCC-16: Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131074.html>10.17917/QATM-6Q97</a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131075.html>10.17917/5NNX-F760</a></td><td>NCL Method PCC-18: Quantitation of APIs in Polymeric Prodrug Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131076.html>10.17917/RW1F-4D43</a></td><td>NCL Method PCC-19: Asymmetric-Flow Field-Flow Fractionation</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131077.html>10.17917/XQ3B-W012</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131078.html>10.17917/K0XB-3581</a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131079.html>10.17917/XJ16-D110</a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131080.html>10.17917/MK26-YD70</a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131081.html>10.17917/1GSW-5N64</a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131082.html>10.17917/2MDV-2445</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131083.html>10.17917/W9YH-YJ13</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131084.html>10.17917/DQZP-7M50</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131085.html>10.17917/0ZHD-SA93</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131086.html>10.17917/4G01-8T87</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131087.html>10.17917/3DE3-3446</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131088.html>10.17917/D0GG-4X14</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131089.html>10.17917/6J6H-3R27</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131090.html>10.17917/WRWV-CW04</a></td><td>NCL Method ITA-5.2: Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131091.html>10.17917/4VDA-ZS32</a></td><td>NCL Method ITA-6: Leukocyte Proliferation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131092.html>10.17917/SX37-3D76</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131093.html>10.17917/NB97-6E21</a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131094.html>10.17917/X2P6-HA51</a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131095.html>10.17917/Q94Q-6B29</a></td><td>NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131096.html>10.17917/W604-T506</a></td><td>NCL Method ITA-8: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131097.html>10.17917/K08Q-Y828</a></td><td>NCL Method ITA-8.1: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131098.html>10.17917/CFBS-5C02</a></td><td>NCL Method ITA-8.2: Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131099.html>10.17917/NQK3-2449</a></td><td>NCL Method ITA-9: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131100.html>10.17917/P4YG-Z672</a></td><td>NCL Method ITA-9.1: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131101.html>10.17917/RXJ2-EG43</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131102.html>10.17917/HVEG-VH85</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131103.html>10.17917/F4CE-FT82</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131104.html>10.17917/2DT9-XS67</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131105.html>10.17917/P6SK-3R71</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131106.html>10.17917/GV9W-FF90</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131107.html>10.17917/72F3-8Z52</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131108.html>10.17917/AJ1Z-2E64</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131109.html>10.17917/NK3Y-2F88</a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131110.html>10.17917/F32N-3W57</a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131111.html>10.17917/C59D-T717</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131112.html>10.17917/3429-7641</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131113.html>10.17917/DKY3-BZ13</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131114.html>10.17917/EWMJ-D959</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131115.html>10.17917/PQVY-GN53</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131116.html>10.17917/BHQ7-GD40</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131117.html>10.17917/X900-GP60</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131118.html>10.17917/S3CM-4J74</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131119.html>10.17917/ZXVG-DA66</a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131120.html>10.17917/ZNS7-4E84</a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131121.html>10.17917/D4XK-WH24</a></td><td>NCL Method ITA-27: Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131122.html>10.17917/E65B-GP64</a></td><td>NCL Method ITA-29: Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131123.html>10.17917/06V6-WD77</a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131124.html>10.17917/1RPW-X912</a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131125.html>10.17917/GJ0C-JY85</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131126.html>10.17917/8FKW-D647</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131127.html>10.17917/8BPC-VN29</a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131128.html>10.17917/SGVV-N363</a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131129.html>10.17917/NG6J-WH37</a></td><td>NCL Method ITA-40: Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131130.html>10.17917/WPJB-EE02</a></td><td>NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131131.html>10.17917/5S8G-WB35</a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131132.html>10.17917/WV7C-JG27</a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131133.html>10.17917/BFZH-QN35</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131134.html>10.17917/DWFK-8B95</a></td><td>NCL Method GTA-3: Hep G2 Hepatocyte Glutathione Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131135.html>10.17917/NGR4-KR46</a></td><td>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131136.html>10.17917/J2HN-5116</a></td><td>NCL Method GTA-5: LLC-PK1 Kidney Cell Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131137.html>10.17917/RJYY-4562</a></td><td>NCL Method GTA-6: HepG2 Hepatocarcinoma Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131138.html>10.17917/PP52-SF51</a></td><td>NCL Method GTA-7: Hepatocyte Primary ROS Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131139.html>10.17917/BAWN-K053</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131140.html>10.17917/F3HK-FC87</a></td><td>NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131141.html>10.17917/ZMDT-FP49</a></td><td>NCL Method GTA-13: In Vitro Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131142.html>10.17917/BPA7-XK19</a></td><td>NCL Method GTA-14: Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131143.html>10.17917/P2B0-5211</a></td><td>NCL Method PHA-1: Radioactive Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131144.html>10.17917/97H6-ZZ07</a></td><td>NCL Method PHA-2: Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131146.html>10.17917/0DFX-GC30</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131147.html>10.17917/6KEP-3R19</a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131148.html>10.17917/373S-6W98</a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131149.html>10.17917/2EEV-MY50</a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131150.html>10.17917/C73S3Q</a></td><td>NIST-NCL Joint Assay Protocol, PCC-11: Method for Determination of the Mass Fraction of Particle-Bound Gold in Suspensions of Gold Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131151.html>10.17917/C73W2C </a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131152.html>10.17917/C74D4M</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131153.html>10.17917/C7201Q</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Liposomal Products</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131154.html>10.17917/C73011</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Colloidal Metal Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131155.html>10.17917/C76P40</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Polymeric Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131156.html>10.17917/GS4R-4H02</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131157.html>10.17917/NZYM-3K29</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131158.html>10.17917/PJNB-JJ95</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131159.html>10.17917/C70013</a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131160.html>10.17917/C7059V</a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131161.html>10.17917/C7G596</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131162.html>10.17917/C7J012</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131163.html>10.17917/C7BC78</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131164.html>10.17917/C77P49</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131165.html>10.17917/C7PP4B </a></td><td>Endotoxin and Depyrogenation Guide</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131166.html>10.17917/C7NP41</a></td><td>NCL Method ITA-38: Analysis of Nanoparticle Effects on IgE-Dependent Mast Cell Degranulation </td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131167.html>10.17917/BND8-T188</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131197.html>10.17917/WZGC-DG48</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539136.html>10.17917/ZB8P-FB40 </a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539138.html>10.17917/1VHC-MJ13 </a></td><td>NCL Method PCC-16: Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539139.html>10.17917/JM45-VA25</a></td><td>NCL Method PCC-18: Quantitation of APIs in Polymeric Prodrug Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539140.html>10.17917/8S1D-BN17 </a></td><td>NCL Method PCC-19: Asymmetric-Flow Field-Flow Fractionation</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539141.html>10.17917/WF0H-1V72 </a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539142.html>10.17917/V9AP-D094 </a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539143.html>10.17917/0165-RC67 </a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539144.html>10.17917/7GEJ-8G77</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539145.html>10.17917/YTHD-KF51</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539146.html>10.17917/822G-S949 </a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539147.html>10.17917/HA0Q-5B49</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539148.html>10.17917/EQCT-3C51</a></td><td>NCL Method ITA-5.2: Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88539149.html>10.17917/C8XW-BQ05</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834048.html>10.17917/B68Q-T959</a></td><td>Supplement to NIST-NCL Joint Assay Protocols PCC-8 & PCC-9: Metal Quantitation by Inductively Coupled Plasma-Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834054.html>10.17917/WBSK-2W04 </a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834056.html>10.17917/GS4C-N171</a></td><td>NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834057.html>10.17917/M173-MY22  </a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834059.html>10.17917/QENR-XG24</a></td><td>NCL Method ITA-8.2: Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834060.html>10.17917/CPWX-SP39</a></td><td>NCL Method ITA-8.1: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834061.html>10.17917/ZTXV-XC08</a></td><td>NCL Method ITA-9.1: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834062.html>10.17917/WZGC-DG48</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834063.html>10.17917/GBQR-BN14</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834064.html>10.17917/416C-5429 </a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834065.html>10.17917/7SF3-7A88</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834066.html>10.17917/ZQ6R-KD69 </a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834067.html>10.17917/GMXG-BH29</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834068.html>10.17917/RD78-BZ75</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834069.html>10.17917/JQM0-0G48</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834070.html>10.17917/SJT2-7P72</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/88834071.html>10.17917/DM9W-8430 </a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/100335618.html>10.17917/P2T3-8P84</a></td><td>NCL Method ITA-27: Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/110788608.html>10.17917/30CJ-2J27 </a></td><td>NCL Method STE-2.2: Detection of Bacterial Contamination Using Luria Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/112853000.html>10.17917/DVJF-SS25 </a></td><td>NCL Method STE-2.1: Detection of Microbial Contamination Using Millipore Sampler Devices</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130946.html>10.17917/WFT5-1J52 </a></td><td>NCL Method STE-2.3: Detection of Bacterial Contamination Using Tryptic Soy Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130947.html>10.17917/86Y9-3Y16 </a></td><td>NCL Method STE-2.4: Detection of Bacterial Contamination using Tryptic Soy Agar Plates and RPMI Suspension Tests for the Purposes of Determining Bacterial ID</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130949.html>10.17917/G780-R621</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130950.html>10.17917/SCP8-6P58</a></td><td>NCL Method PCC-21: Measuring Size and Number Concentration of Metallic Nanoparticles using SP-ICP-MS</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130951.html>10.17917/QFEP-HD46</a></td><td>NCL Method PCC-22: Residual Organic Solvent Analysis in Nanoformulations Using Headspace Gas Chromatography</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130952.html>10.17917/7Z55-SJ80</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130954.html>10.17917/B5N6-F154</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Liposomal Products</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130955.html>10.17917/2MYC-DE76</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Colloidal Metal Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130956.html>10.17917/G13J-XR95</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Polymeric Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130957.html>10.17917/W63A-GR02 </a></td><td>Guide to NCL In Vivo Studies: Efficacy, Pharmacokinetics and Toxicology</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130958.html>10.17917/PBZB-N042 </a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130959.html> 10.17917/EYQD-3T61 </a></td><td>NCL Method ITA-29: Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130960.html>10.17917/C7K01C</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130961.html>10.17917/C7KW2Q </a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130962.html>10.17917/0J6M-EJ19 </a></td><td>NCL Method ITA-40: Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130963.html>10.17917/BA6D-TE29</a></td><td>NCL Method STE-4: Detection of Œ?-glucan contamination</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130988.html>10.17917/PHFP-8573 </a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130989.html>10.17917/B6HB-C950 </a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130990.html>10.17917/VRHF-5Y74 </a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130991.html>10.17917/RK6R-P820 </a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130992.html>10.17917/5WSQ-7X78</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130993.html>10.17917/3F5S-6728</a></td><td>NIST-NCL Joint Assay Protocol, PCC-1: Measuring the Size of Nanoparticles in Aqueous Media Using Batch-Mode Dynamic Light Scattering</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130994.html>10.17917/DHAG-PC35</a></td><td>NIST-NCL Joint Assay Protocol, PCC-6: Size Measurement of Nanoparticles Using Atomic Force Microscopy</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130995.html>10.17917/C7N7-N938</a></td><td>NIST-NCL Joint Assay Protocol, PCC-7: Measuring the Size of Nanoparticles Using Transmission Electron Microscopy (TEM)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130996.html>10.17917/SA6R-9D63</a></td><td>NIST-NCL Joint Assay Protocol, PCC-8: Determination of Gold in Rat Tissue with Inductively Coupled Plasma Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130997.html>10.17917/3THH-7C14</a></td><td>NIST-NCL Joint Assay Protocol, PCC-9: Determination of Gold in Rat Blood with Inductively Coupled Plasma Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130998.html>10.17917/0QDS-ZT72</a></td><td>NIST-NCL Joint Assay Protocol, PCC-10: Analysis of Gold Nanoparticles by Electrospray Differential Mobility Analysis (ES-DMA)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114130999.html>10.17917/2ZKD-6321</a></td><td>NIST-NCL Joint Assay Protocol, PCC-11: Method for Determination of the Mass Fraction of Particle-Bound Gold in Suspensions of Gold Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131000.html>10.17917/9Q5G-G245</a></td><td>NIST-NCL Joint Assay Protocol, PCC-12: Measuring the Electrolytic Conductivity of Nanoparticle Suspensions</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131001.html>10.17917/YNXM-AD40</a></td><td>NIST-NCL Joint Assay Protocol, PCC-13: Measuring the pH of Nanoparticle Suspensions</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131002.html>10.17917/NHEE-7838</a></td><td>NIST-NCL Joint Assay Protocol, PCC-15: Measuring the Size of Colloidal Gold Nano-particles using HighResolution Scanning Electron Microscopy</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131003.html>10.17917/X6PD-WC14</a></td><td>NIST-NCL Joint Assay Protocol, PCC-14: Quantification of Free and Chelated Gadolinium Species in Nanoemulsion-Based Magnetic Resonance Imaging Contrast Agent Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131004.html>10.17917/C75P4P</a></td><td>NCL Method PCC-23: Quantitation of Residual DMSO in Nanoformulations Using Gas Chromatography with Direct Injection and Flame Ionization Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131005.html>10.17917/2HFK-9E25 </a></td><td>NCL Method PHA-1: Radioactive Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131006.html>10.17917/8EJ1-9P65</a></td><td>NCL Method PHA-2: Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131007.html>10.17917/Q6EC-XC97 </a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131008.html>10.17917/96Z2-NZ61</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131009.html> 10.17917/EHR9-HB86 </a></td><td>NCL Method GTA-3: Hep G2 Hepatocyte Glutathione Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131010.html>10.17917/H65D-SJ70</a></td><td>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131011.html>10.17917/E9YS-N327 </a></td><td>NCL Method GTA-5: LLC-PK1 Kidney Cell Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131012.html>10.17917/3F7T-M688 </a></td><td>NCL Method GTA-6: HepG2 Hepatocarcinoma Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131013.html>10.17917/0WF6-GX40 </a></td><td>NCL Method GTA-7: Hepatocyte Primary ROS Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131014.html>10.17917/WY7Z-MD10</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131015.html>10.17917/YPTH-N396 </a></td><td>NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131016.html>10.17917/95VC-ZP26</a></td><td>NCL Method GTA-14: Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131017.html>10.17917/T6JC-ZG30 </a></td><td>NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131018.html>10.17917/0YC3-6793</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131019.html>10.17917/Y4CQ-SV79</a></td><td>NCL Method ITA-26: Detection of Intracellular Complement Activation in Human T Lymphocytes</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131020.html>10.17917/PRQZ-3095</a></td><td>NCL Method ITA-31: Detection of Nanoparticle-Mediated Total Oxidative Stress in T Cells Using CM-H2DC-FDA Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131021.html>10.17917/HWV7-3E78</a></td><td>NCL Method ITA-32: Detection of Mitochondrial Oxidative Stress in T Cells Using MitoSOX Red Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131022.html>10.17917/RTMF-4853</a></td><td>NCL Method ITA-33: Detection of Changes in Mitochondrial Membrane Potential in T Cells Using JC-1 Dye</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131023.html>10.17917/YTEJ-F575</a></td><td>NCL Method ITA-34: Detection of Antigen Presentation by Murine Bone Marrow-Derived Dendritic Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131024.html>10.17917/1QRB-NC62</a></td><td>NCL Method ITA-35: Antigen-Specific Stimulation of CD8+ T Cells by Murine Bone Marrow-Derived Dendritic Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131059.html>10.17917/A20K-T950</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131060.html>10.17917/VZ9M-8351</a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131061.html>10.17917/MQJP-YG07</a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131062.html>10.17917/P9TT-MN30</a></td><td>NCL Method STE-2.1: Detection of Microbial Contamination Using Millipore Sampler Devices</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131063.html>10.17917/5JCE-HQ72</a></td><td>NCL Method STE-2.2: Detection of Bacterial Contamination Using Luria Broth Agar Plates</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131064.html>10.17917/QCFR-6F07</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131065.html>10.17917/916B-JQ80</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131066.html>10.17917/54TK-DG93</a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131067.html>10.17917/XCBE-2712</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131068.html>10.17917/R1XZ-X580</a></td><td>NCL Method STE-3: Detection of Mycoplasma Contamination in Nanoparticle Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131069.html>10.17917/8XN0-3373</a></td><td>Endotoxin and Depyrogenation Tips</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131070.html>10.17917/71WC-AN25</a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131071.html>10.17917/NF9V-MM03</a></td><td>NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131072.html>10.17917/MP68-WN76</a></td><td>Supplement to NIST-NCL Joint Assay Protocols PCC-8 & PCC-9: Metal Quantitation by Inductively Coupled Plasma-Mass Spectrometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131073.html>10.17917/Y597-RM86</a></td><td>NCL Method PCC-16: Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131074.html>10.17917/QATM-6Q97</a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131075.html>10.17917/5NNX-F760</a></td><td>NCL Method PCC-18: Quantitation of APIs in Polymeric Prodrug Formulations</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131076.html>10.17917/RW1F-4D43</a></td><td>NCL Method PCC-19: Asymmetric-Flow Field-Flow Fractionation</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131077.html>10.17917/XQ3B-W012</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131078.html>10.17917/K0XB-3581</a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131079.html>10.17917/XJ16-D110</a></td><td>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131080.html>10.17917/MK26-YD70</a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131081.html>10.17917/1GSW-5N64</a></td><td>NCL Method ITA-2.1: Analysis of Platelet Aggregation by Cell Counting</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131082.html>10.17917/2MDV-2445</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131083.html>10.17917/W9YH-YJ13</a></td><td>NCL Method ITA-2.2: Analysis of Platelet Aggregation by Light Transmission Aggregometry</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131084.html>10.17917/DQZP-7M50</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131085.html>10.17917/0ZHD-SA93</a></td><td>NCL Method ITA-3: Mouse Granulocyte-Macrophage Colony-Forming Unit Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131086.html>10.17917/4G01-8T87</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131087.html>10.17917/3DE3-3446</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131088.html>10.17917/D0GG-4X14</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131089.html>10.17917/6J6H-3R27</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131090.html>10.17917/WRWV-CW04</a></td><td>NCL Method ITA-5.2: Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131091.html>10.17917/4VDA-ZS32</a></td><td>NCL Method ITA-6: Leukocyte Proliferation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131092.html>10.17917/SX37-3D76</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131093.html>10.17917/NB97-6E21</a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131094.html>10.17917/X2P6-HA51</a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131095.html>10.17917/Q94Q-6B29</a></td><td>NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131096.html>10.17917/W604-T506</a></td><td>NCL Method ITA-8: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131097.html>10.17917/K08Q-Y828</a></td><td>NCL Method ITA-8.1: Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131098.html>10.17917/CFBS-5C02</a></td><td>NCL Method ITA-8.2: Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131099.html>10.17917/NQK3-2449</a></td><td>NCL Method ITA-9: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131100.html>10.17917/P4YG-Z672</a></td><td>NCL Method ITA-9.1: Phagocytosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131101.html>10.17917/RXJ2-EG43</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131102.html>10.17917/HVEG-VH85</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131103.html>10.17917/F4CE-FT82</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131104.html>10.17917/2DT9-XS67</a></td><td>NCL Method ITA-11: Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131105.html>10.17917/P6SK-3R71</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131106.html>10.17917/GV9W-FF90</a></td><td>NCL Method ITA-12: In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131107.html>10.17917/72F3-8Z52</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131108.html>10.17917/AJ1Z-2E64</a></td><td>NCL Method ITA-14: Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131109.html>10.17917/NK3Y-2F88</a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131110.html>10.17917/F32N-3W57</a></td><td>NCL Method ITA-17: Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131111.html>10.17917/C59D-T717</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131112.html>10.17917/3429-7641</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131113.html>10.17917/DKY3-BZ13</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131114.html>10.17917/EWMJ-D959</a></td><td>NCL Method ITA-22: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131115.html>10.17917/PQVY-GN53</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131116.html>10.17917/BHQ7-GD40</a></td><td>NCL Method ITA-23: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1Œ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131117.html>10.17917/X900-GP60</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131118.html>10.17917/S3CM-4J74</a></td><td>NCL Method ITA-24: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNFŒ± in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131119.html>10.17917/ZXVG-DA66</a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131120.html>10.17917/ZNS7-4E84</a></td><td>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNŒ? in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131121.html>10.17917/D4XK-WH24</a></td><td>NCL Method ITA-27: Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131122.html>10.17917/E65B-GP64</a></td><td>NCL Method ITA-29: Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131123.html>10.17917/06V6-WD77</a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131124.html>10.17917/1RPW-X912</a></td><td>NCL Method ITA-36: Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131125.html>10.17917/GJ0C-JY85</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131126.html>10.17917/8FKW-D647</a></td><td>NCL Method ITA-37.1: Immunophenotyping‚ÄîInstrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131127.html>10.17917/8BPC-VN29</a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131128.html>10.17917/SGVV-N363</a></td><td>NCL Method ITA-37.2: Immunophenotyping‚ÄîAnalysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131129.html>10.17917/NG6J-WH37</a></td><td>NCL Method ITA-40: Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131130.html>10.17917/WPJB-EE02</a></td><td>NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131131.html>10.17917/5S8G-WB35</a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131132.html>10.17917/WV7C-JG27</a></td><td>NCL Method GTA-1: LLC-PK1 Kidney Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131133.html>10.17917/BFZH-QN35</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131134.html>10.17917/DWFK-8B95</a></td><td>NCL Method GTA-3: Hep G2 Hepatocyte Glutathione Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131135.html>10.17917/NGR4-KR46</a></td><td>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131136.html>10.17917/J2HN-5116</a></td><td>NCL Method GTA-5: LLC-PK1 Kidney Cell Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131137.html>10.17917/RJYY-4562</a></td><td>NCL Method GTA-6: HepG2 Hepatocarcinoma Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131138.html>10.17917/PP52-SF51</a></td><td>NCL Method GTA-7: Hepatocyte Primary ROS Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131139.html>10.17917/BAWN-K053</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131140.html>10.17917/F3HK-FC87</a></td><td>NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131141.html>10.17917/ZMDT-FP49</a></td><td>NCL Method GTA-13: In Vitro Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131142.html>10.17917/BPA7-XK19</a></td><td>NCL Method GTA-14: Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131143.html>10.17917/P2B0-5211</a></td><td>NCL Method PHA-1: Radioactive Blood Partitioning Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131144.html>10.17917/97H6-ZZ07</a></td><td>NCL Method PHA-2: Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131146.html>10.17917/0DFX-GC30</a></td><td>NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131147.html>10.17917/6KEP-3R19</a></td><td>NCL Method STE-1.4: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Chromogenic LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131148.html>10.17917/373S-6W98</a></td><td>NCL Method STE-1.3: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Gel-Clot LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131149.html>10.17917/2EEV-MY50</a></td><td>NCL Method STE-1.2: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the Kinetic Turbidity LAL Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131150.html>10.17917/C73S3Q</a></td><td>NIST-NCL Joint Assay Protocol, PCC-11: Method for Determination of the Mass Fraction of Particle-Bound Gold in Suspensions of Gold Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131151.html>10.17917/C73W2C </a></td><td>NCL Method PCC-17: Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131152.html>10.17917/C74D4M</a></td><td>NCL Method PCC-20: Particle Concentration and Size using the Spectradyne nCS1</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131153.html>10.17917/C7201Q</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Liposomal Products</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131154.html>10.17917/C73011</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Colloidal Metal Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131155.html>10.17917/C76P40</a></td><td>Parameters, Methods, and Considerations for the Physicochemical Characterization of Polymeric Nanoparticles</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131156.html>10.17917/GS4R-4H02</a></td><td>NCL Method ITA-4: Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131157.html>10.17917/NZYM-3K29</a></td><td>NCL Method ITA-5.1: Qualitative Analysis of Total Complement Activation by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131158.html>10.17917/PJNB-JJ95</a></td><td>NCL Method ITA-6.1: Leukocyte Proliferation Assay (Immunostimulation and Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131159.html>10.17917/C70013</a></td><td>NCL Method ITA-6.2: Leukocyte Proliferation Assay (Immunostimulation)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131160.html>10.17917/C7059V</a></td><td>NCL Method ITA-6.3: Leukocyte Proliferation Assay (Immunosuppression)</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131161.html>10.17917/C7G596</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131162.html>10.17917/C7J012</a></td><td>NCL Method ITA-18: Human Lymphocyte Activation (HuLa) Assay for Analysis of Immunosuppressive Properties of Nanomaterials</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131163.html>10.17917/C7BC78</a></td><td>NCL Method GTA-2: Hep G2 Hepatocarcinoma Cytotoxicity Assay</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131164.html>10.17917/C77P49</a></td><td>NCL Method GTA-11: Autophagic Dysfunction Assay‚ÄîQualitative Analysis of MAP LC3-I to LC3-II Conversion by Western Blot</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131165.html>10.17917/C7PP4B </a></td><td>Endotoxin and Depyrogenation Guide</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131166.html>10.17917/C7NP41</a></td><td>NCL Method ITA-38: Analysis of Nanoparticle Effects on IgE-Dependent Mast Cell Degranulation </td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131167.html>10.17917/BND8-T188</a></td><td>NCL Method ITA-10: Preparation of Human Whole Blood and Peripheral Blood Mononuclear Cell Cultures to Analyze Nanoparticle Potential to Induce Cytokines In Vitro</td></tr><tr><td><a href=https://cbiit.github.io/NCI-DOI-LandingPages/caNanoLab/114131197.html>10.17917/WZGC-DG48</a></td><td>NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</td></tr></table</body></html>